epinephrine

Generic: epinephrine

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name epinephrine
Generic Name epinephrine
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients

epinephrine .15 mg/.15mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1321
Product ID 51662-1321_11c162e8-8210-3fdd-e063-6294a90afc68
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA201739
Listing Expiration 2026-12-31
Marketing Start 2018-09-21

Pharmacologic Class

Established (EPC)
alpha-adrenergic agonist [epc] beta-adrenergic agonist [epc] catecholamine [epc]
Mechanism of Action
adrenergic alpha-agonists [moa] adrenergic beta-agonists [moa]
Chemical Structure
catecholamines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621321
Hyphenated Format 51662-1321

Supplemental Identifiers

RxCUI
1870205 1870232
UPC
0060842022011
UNII
YKH834O4BH
NUI
N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name epinephrine (source: ndc)
Generic Name epinephrine (source: ndc)
Application Number NDA201739 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • .15 mg/.15mL
source: ndc
Packaging
  • .15 mL in 1 DOSE PACK (51662-1321-1)
  • 2 DOSE PACK in 1 CARTON (51662-1321-2) / .15 mL in 1 DOSE PACK
source: ndc

Packages (2)

51662-1321-1 .15 mL in 1 DOSE PACK (51662-1321-1) 51662-1321-2 2 DOSE PACK in 1 CARTON (51662-1321-2) / .15 mL in 1 DOSE PACK

Ingredients (1)

epinephrine (.15 mg/.15mL)

Linked Drug Pages (1)

EPINEPHRINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "11c162e8-8210-3fdd-e063-6294a90afc68", "openfda": {"nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "upc": ["0060842022011"], "unii": ["YKH834O4BH"], "rxcui": ["1870205", "1870232"], "spl_set_id": ["7664bb0d-dc1a-ca8b-e053-2991aa0ad627"], "pharm_class_cs": ["Catecholamines [CS]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": ".15 mL in 1 DOSE PACK (51662-1321-1)", "package_ndc": "51662-1321-1", "marketing_start_date": "20180921"}, {"sample": false, "description": "2 DOSE PACK in 1 CARTON (51662-1321-2)  / .15 mL in 1 DOSE PACK", "package_ndc": "51662-1321-2", "marketing_start_date": "20190824"}], "brand_name": "EPINEPHRINE", "product_id": "51662-1321_11c162e8-8210-3fdd-e063-6294a90afc68", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Catecholamine [EPC]", "Catecholamines [CS]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1321", "generic_name": "EPINEPHRINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EPINEPHRINE", "active_ingredients": [{"name": "EPINEPHRINE", "strength": ".15 mg/.15mL"}], "application_number": "NDA201739", "marketing_category": "NDA", "marketing_start_date": "20180921", "listing_expiration_date": "20261231"}